Arbutus Biopharma Corporation Common Stock Share Price
NASDAQ: ABUSHealthcare
Live Arbutus Biopharma Corporation Common Stock Share Price Chart
O H L
Arbutus Biopharma Corporation Common Stock Performance Overview
Days Range
▼
$5.04Low
$5.05High
Markets Today
| Previous Close | $5.07 |
|---|---|
| Open | $5.04 |
| Volume | 432,462 |
| Day's Range | $5.04 - $5.05 |
| 52W Range | $3.50 - $5.45 |
| Market Cap | $1.00 B |
Historical Performance
| 1M Returns | +4.75 |
|---|---|
| 3M Returns | +11.43 |
| 6M Returns | +19.29 |
| 1Y Returns | +14.71 |
| 5Y Returns | +16.55 |
| 10Y Returns | +35.92 |
Arbutus Biopharma Corporation Common Stock Fundamentals
| Market Cap | $1.00 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 6.45 |
| PEG Ratio | N/A |
| Revenue | $14.08 M |
| ROE TTM | -0.39 |
| EPS TTM | $0.78 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.86 |
| EBITDA | $-24.86 M |
| Profit Margin | -237.88 |
| Market Cap | $1.00 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 6.45 |
| PEG Ratio | N/A |
| Revenue | $14.08 M |
| ROE TTM | -0.39 |
| EPS TTM | $0.78 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.86 |
| EBITDA | $-24.86 M |
| Profit Margin | -237.88 |
Arbutus Biopharma Corporation Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $1.76 M | $10.74 M | $529.00 K | $1.05 M | $179.13 M | $1.01 M |
| Gross Profit + | $1.76 M | $10.74 M | $529.00 K | $1.05 M | $179.13 M | $1.01 M |
| Operating Income | -$25.70 M | $1.49 M | -$8.66 M | -$5.29 M | $168.91 M | -$5.96 M |
| EBITDA | -$13.00 M | $1.66 M | -$8.55 M | -$4.98 M | $168.92 M | -$5.95 M |
| Interest Expense | -$28.00 K | -$28.00 K | -$23.00 K | -$18.00 K | -$17.00 K | -$18.00 K |
| Depreciation | $12.70 M | $176.00 K | $109.00 K | $314.00 K | $11.00 K | $11.00 K |
| Income Before Tax | -$24.53 M | $2.50 M | -$7.74 M | -$3.76 M | $169.69 M | -$5.19 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$24.53 M | $2.50 M | -$7.74 M | -$3.76 M | $169.69 M | -$5.19 M |
| Net Profit Margin | -1390.36% | 23.3% | -1463.52% | -357.37% | 94.73% | -512.03% |
Arbutus Biopharma Corporation Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.42 B | $1.42 B | $1.42 B | $1.42 B | $1.44 B | $1.45 B |
| Reserve & Surplus | -$1.42 B | -$1.42 B | -$1.42 B | -$1.43 B | -$1.26 B | -$1.26 B |
| Non-Current Liabilities | $18.42 M | $15.27 M | $15.13 M | $12.04 M | $11.88 M | $11.93 M |
| Current Liabilities | $19.43 M | $5.02 M | $5.18 M | $6.01 M | $5.11 M | $3.36 M |
| Total Liabilities | $37.85 M | $20.29 M | $20.31 M | $18.04 M | $16.99 M | $15.29 M |
| Fixed Assets | $168.00 K | $148.00 K | $137.00 K | $32.00 K | $22.00 K | $10.00 K |
| Current Assets | $116.81 M | $103.12 M | $97.44 M | $94.46 M | $277.01 M | $273.88 M |
| Total Assets | $117.01 M | $103.27 M | $97.71 M | $94.62 M | $277.16 M | $274.02 M |
Arbutus Biopharma Corporation Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$24.53 M | $2.52 M | -$7.74 M | -$3.76 M | $169.69 M | -$5.14 M |
| Operating Cash Flow | -$13.39 M | -$15.75 M | -$5.82 M | -$4.68 M | -$8.11 M | -$6.02 M |
| Investing Cash Flow | $11.35 M | $15.61 M | -$10.02 M | -$1.36 M | $2.20 M | -$1.66 M |
| Financing Cash Flow | $2.78 M | $453.00 K | $844.00 K | $1.64 M | $11.62 M | $3.15 M |
| Change in Cash | $746.00 K | $336.00 K | -$15.00 M | -$4.40 M | $5.70 M | -$4.54 M |
Arbutus Biopharma Corporation Common Stock Return Calculator
The Arbutus Biopharma Corporation Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$11,540
Invested Amount$10,000
Est. Returns$1,540
About Arbutus Biopharma Corporation Common Stock
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Popular Stocks
FAQs
What is the share price of Arbutus Biopharma Corporation Common Stock today?
Arbutus Biopharma Corporation Common Stock (ABUS) share price as of September 18, 2026 is $5.02. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Arbutus Biopharma Corporation Common Stock?
Yes, Indian Investors can invest in the Arbutus Biopharma Corporation Common Stock (ABUS) Share by opening an international trading account with Angel One.
How can I purchase Arbutus Biopharma Corporation Common Stock shares in India?
Purchasing Arbutus Biopharma Corporation Common Stock (ABUS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Arbutus Biopharma Corporation Common Stock (ABUS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Arbutus Biopharma Corporation Common Stock?
Yes, you can purchase fractional shares of Arbutus Biopharma Corporation Common Stock (ABUS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Arbutus Biopharma Corporation Common Stock?
The market capitalization of Arbutus Biopharma Corporation Common Stock on September 18, 2026, is $1.00 B.
In which sector Arbutus Biopharma Corporation Common Stock belongs?
Arbutus Biopharma Corporation Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Arbutus Biopharma Corporation Common Stock stocks?
In order to invest in Arbutus Biopharma Corporation Common Stock (ABUS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
